HAPLN1 confers multiple myeloma cell resistance to several classes of therapeutic drugs

• Mailee Huynh ,

  Contributed equally to this work with: Mailee Huynh, Hae Yeun Chang

  Roles Conceptualization, Data curation, Funding acquisition, Investigation, Methodology, Validation, Visualization, Writing – original draft

  Affiliations Department of Oncology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, United States of America, McArdle Laboratory for Cancer Research, Madison, WI, United States of America

  ⨯
• Hae Yeun Chang ,

  Contributed equally to this work with: Mailee Huynh, Hae Yeun Chang

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft

  Affiliations Department of Oncology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, United States of America, McArdle Laboratory for Cancer Research, Madison, WI, United States of America

  ⨯
• Dominique N. Lisiero,

  Roles Data curation, Investigation, Methodology, Writing – review & editing

  Affiliations Department of Oncology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, United States of America, McArdle Laboratory for Cancer Research, Madison, WI, United States of America

  ⨯
• Irene M. Ong,

  Roles Formal analysis, Methodology, Software, Writing – review & editing

  Affiliations Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, United States of America, University of Wisconsin Carbone Cancer Center (UWCCC), Madison, WI, United States of America

  ⨯
• Trinayan Kashyap,

  Roles Conceptualization, Resources, Writing – review & editing

  Affiliation Karyopharm Therapeutics, Inc., Newton, MA, United States of America

  ⨯
• Natalie S. Callander,

  Roles Conceptualization, Writing – review & editing

  Affiliation Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, United States of America

  ⨯
• Shigeki Miyamoto

  Roles Conceptualization, Funding acquisition, Project administration, Supervision, Writing – original draft

  * E-mail: smiyamot@wisc.edu

  Affiliations Department of Oncology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, United States of America, McArdle Laboratory for Cancer Research, Madison, WI, United States of America, University of Wisconsin Carbone Cancer Center (UWCCC), Madison, WI, United States of America

  https://orcid.org/0000-0002-7827-3426

  ⨯